DESCRIPTION:

A method and means is described for reducing or eliminating hyperglycemia. In particular, a means for non-invasively treating hyperglycemia patients who have renal failure and are undergoing dialysis treatments described.  The technology significantly increases glucose utilization non-pharmacology and has no know complications.

ADVANTAGES:

Non-Invasive, low cost, easy to implement, few if any complications

DISADVANTAGES:

The inventor is unaware of any other device markets with claims of reducing hyperglycemia. Insulin gluconeogenesis inhibitors (e.g. Wetformin) are this standard pharmacologic approaches, but these have fallout if the patient is experiencing rental failure

PATENT STATUS:

Patent application is being finalized.